Prospero Int Consulting
Regulatory, pharmacovigilance and business process consulting for pharmaceutical, biotech and healthcare companies
Highlights
- New on EvolcAdded 2026-11-16
About Prospero Int Consulting
Prospero Int Consulting provides regulatory affairs, pharmacovigilance and compliance services to pharmaceutical and healthcare businesses. It also offers business analyst services, ERP implementation support and business process management for digital transformation and operational improvement.
The firm serves biotech and pharmaceutical companies of different sizes worldwide, as well as small and medium-sized businesses. It is based in the United Kingdom and is registered in Windsor; founded in 2014.
Product: Regulatory affairs, pharmacovigilance, compliance, business analyst and business process management consulting services.
Jobs at Prospero Int Consulting
More consulting & professional services companies
Prosperohub
HubSpot CRM implementation, migration, onboarding and RevOps consulting for B2B companies in the UK and EMEANew on EvolcRemote-friendlyProspex Accounting
Chartered accountancy and financial advisory services for individuals, company owners and SMEs in the UKYoung companyNew on EvolcProtego Tax
Private-client tax planning and compliance services for high-net-worth individuals, families and internationally mobile clientsYoung companyNew on EvolcProtian
Business intelligence, transformation and project management consultancy for businesses seeking to simplify operationsNew on EvolcProtolan
Food and drink manufacturing project management and engineering services for producers worldwideNew on EvolcProview Accounting
Accounting, tax and business advisory services for startups, SMEs and other businesses in LondonNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
No confirmed website technologies in the latest recorded checks.
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.